Posts in tag

Diabetes


Debbie Rigby rounds up the latest in research news Regular use of proton pump inhibitors and risk of type 2 diabetes A prospective analysis over 200,000 participants shows an association …

Debbie Rigby takes a look at the latest in research news Medication-related osteonecrosis of the jaw Analysis of the Australian database of adverse event notifications identified medications reported to cause …

Debbie Rigby takes a look at the latest in research news Update on Asthma–COPD Overlap Clinical features of asthma and COPD may represent around 25% of patients with COPD and …

Debbie Rigby takes a look at the latest in research news A primer on medicinal cannabis safety and potential adverse effects The aim of this review is to discuss the …

This week saw a watershed moment for community pharmacy and the COVID-19 vaccination… but also continued controversy about the jab In big news for community pharmacy this week, pharmacist immuniser …

Aged care residents with type 2 diabetes are potentially being overtreated – or missing out on treatment altogether A new international study led by Monash’s Centre for Medicine Use and …

Brad Butt takes an up-close look at a growing issue Diabetes is: Estimated to affect 1.2 million or 5% of the Australian population Diabetes is ranked in the top 10 …

Debbie Rigby rounds up the latest in research news Colchicine and the heart Clinical trials have demonstrated the benefits of colchicine in a range of cardiovascular conditions. Colchicine may reduce …

Debbie Rigby takes a look at the latest in research news Cannabidiol as a Treatment for Chronic Pain In a US-based survey of 253 adults, most participants expressed a positive …

Debbie Rigby rounds up the latest in research news Efficacy and safety of low-dose colchicine in patients with coronary disease A systematic review and meta-analysis of randomized trials indicates that …

Perspectives from Pharmacist and Credentialled Diabetes Educator (CDE), Melina Tandy Starting on insulin can be a daunting experience for many patients with diabetes. Pharmacists can provide key guidance and care …

Transitioning Patients to OPTISULIN® (insulin glargine 100 units/mL) from LANTUS® (insulin glargine 100 units/mL) Optisulin® is the second brand of insulin glargine 100 units/mL from Sanofi1, the manufacturer of Lantus2. …